New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - betaxolol hydrochloride 0.56% equivalent to betaxolol 5 mg/ml;  ;  ;   - eye drops, solution - 0.5 % - active: betaxolol hydrochloride 0.56% equivalent to betaxolol 5 mg/ml       excipient: benzalkonium chloride as 50%soln + 5% overage. equiv. to 0.1mg/ml disodium edetate dihydrate hydrochloric acid purified water sodium chloride sodium hydroxide - the treatment of ocular hypertension or chronic open angle glaucoma. may be used alone or in combination with other iop-lowering medication.

Ireland - English - HPRA (Health Products Regulatory Authority)

pco manufacturing ltd. - betaxolol hydrochloride - eye drops, solution - 0.5% percent weight/volume - beta blocking agents1); betaxolol

Ireland - English - HPRA (Health Products Regulatory Authority)

imbat limited - betaxolol hydrochloride - eye drops, solution - 0.5 base %w/v - beta blocking agents1); betaxolol

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

novartis pharma sa-nv - betaxolol hydrochloride 5,6 mg/ml - eq. betaxolol 5 mg/ml - eye drops, solution - 5 mg/ml - betaxolol hydrochloride 5.6 mg/ml - betaxolol

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

novartis pharma sa-nv - betaxolol hydrochloride 2,8 mg/g - eq. betaxolol 2,5 mg/g - eye drops, suspension - 2,5 mg/ml - betaxolol hydrochloride 2.8 mg/g - betaxolol

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

novartis pharma sa-nv - betaxolol hydrochloride 2,8 mg/ml - eq. betaxolol 2,5 mg/ml - eye drops, suspension - 2,5 mg/ml - betaxolol hydrochloride 2.8 mg/ml - betaxolol

Canada - English - Health Canada

bausch & lomb inc - dorzolamide (dorzolamide hydrochloride) - solution - 20mg - dorzolamide (dorzolamide hydrochloride) 20mg - carbonic anhydrase inhibitors

Ireland - English - HPRA (Health Products Regulatory Authority)

novartis ireland limited - betaxolol hydrochloride - eye drops solution - 0.5 %w/v - betaxolol

Ireland - English - HPRA (Health Products Regulatory Authority)

novartis ireland limited - betaxolol hydrochloride - eye drops suspension - 0.25 %w/v - betaxolol

United States - English - NLM (National Library of Medicine)

a-s medication solutions - dorzolamide hydrochloride (unii: qzo5366ew7) (dorzolamide - unii:9jdx055tw1) - dorzolamide hydrochloride ophthalmic solution, 2% is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. dorzolamide hydrochloride ophthalmic solution is contraindicated in patients who are hypersensitive to any component of this product [see warnings and precautions (5.1)]. there are no adequate and well-controlled studies in pregnant women with dorzolamide hydrochloride ophthalmic solution. dorzolamide caused fetal vertebral malformations when administered orally to rabbits at 2.5 mg/kg/day (37 times the clinical exposure). dorzolamide administered during the period of organogenesis was not teratogenic in rabbits dosed up to 1 mg/kg/day (15 times the clinical exposure). dorzolamide hydrochloride administered orally to rats during late gestation and lactation caused growth delays in offspring at 7.5 mg/kg/day (52 times the clinical exposure). growth was not delayed at 1 mg/kg/day (8.0 times the clinical exposure). the background risk of maj